Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22334435 | 0.90 | THRB (0.32) | ALDH1A1MAPTTHRBTSHR | |
| SCHEMBL22334502 | 0.85 | ALDH1A1 (0.40) | ALDH1A1MAPTTHRBTSHR | |
| SCHEMBL22334441 | 0.81 | ALDH1A1 (0.43) | ALDH1A1MAPTMEN1XBP1KMT2A | |
| SCHEMBL22334447 | 0.79 | ALDH1A1 (0.39) | ALDH1A1MAPTTHRBTSHR | |
| SCHEMBL22334454 | 0.72 | TSHR (0.39) | ALDH1A1THRBTSHR | |
| SCHEMBL8898188 | 0.70 | ALDH1A1 (0.61) | ALDH1A1THRBTSHRTET2 | |
| SCHEMBL22334432 | 0.69 | ALDH1A1 (0.33) | ALDH1A1MAPT | |
| SCHEMBL29026867 | 0.67 | MGAM (0.44) | ALDH1A1MAPTMEN1KMT2ATSHR | |
| SCHEMBL30980015 | 0.67 | HTT (0.48) | ALDH1A1MAPTMEN1KMT2ATSHR | |
| SCHEMBL2548692 | 0.66 | ACHE (0.42) | ALDH1A1THRBTSHRTET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200365945-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2020-11-19 | — | — | US | disclosed |
| EP-3694041-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | Daikin Industries, Ltd. (JP) | 2020-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200365945-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | RER1, CLIC1, PEF1 | ALDH1A1 2101/4885MAPT 4622/4885MEN1 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.